Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease

Lin-Pierre Zhao^{1

2

3}, Maxime Boy^{2

3}, Célia Azoulay², Emmanuelle Clappier⁴, Marie Sébert^{1

5}, Ludivine Amable², Jihene Klibi², Kamel Benlagha², Marion Espéli^{2

3}, Karl Balabanian^{2

3}, Claude Preudhomme^{6

7}, Alice Marceau-Renaut^{6

7}, Lina Benajiba^{5

8}, Raphaël Itzykson^{1

9}, Arsène Mekinian¹⁰, Olivier Fain¹⁰, Antoine Toubert^{2

3

11}, Pierre Fenaux^{1

5}, Nicolas Dulphy^#^{2

3

11}, Lionel Adès^#^{12

13}

Affiliations

¹ Université de Paris, Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
² Université de Paris, Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, Paris, France.
³ CNRS, GDR3697 "Microenvironment of tumor niches - Micronit", Paris, France.
⁴ Université de Paris, Laboratory of Hematology, AP-HP, Hôpital Saint-Louis, Paris, France.
⁵ Université de Paris, Institut de Recherche Saint-Louis, INSERM U944, Paris, France.
⁶ Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France.
⁷ INSERM Lille, University of Lille, Lille, France.
⁸ Université de Paris, Clinical Investigations Center, Hôpital Saint-Louis, AP-HP, Paris, France.
⁹ Université de Paris, INSERM/Centre National de la Recherche Scientifique, Unité Mixte de Recherche 944/7212, Paris Cancer Research Institute, Paris, France.
¹⁰ Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Saint-Antoine, AP-HP, Paris, France.
¹¹ Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France.
¹² Université de Paris, Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France. lionel.ades@aphp.fr.
¹³ Université de Paris, Institut de Recherche Saint-Louis, INSERM U944, Paris, France. lionel.ades@aphp.fr.

^# Contributed equally.

Lin-Pierre Zhao et al. Leukemia. 2021 Sep.

. 2021 Sep;35(9):2720-2724.

doi: 10.1038/s41375-021-01152-1. Epub 2021 Feb 23.

¹ Université de Paris, Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
² Université de Paris, Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, Paris, France.
³ CNRS, GDR3697 "Microenvironment of tumor niches - Micronit", Paris, France.
⁴ Université de Paris, Laboratory of Hematology, AP-HP, Hôpital Saint-Louis, Paris, France.
⁵ Université de Paris, Institut de Recherche Saint-Louis, INSERM U944, Paris, France.
⁶ Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France.
⁷ INSERM Lille, University of Lille, Lille, France.
⁸ Université de Paris, Clinical Investigations Center, Hôpital Saint-Louis, AP-HP, Paris, France.
⁹ Université de Paris, INSERM/Centre National de la Recherche Scientifique, Unité Mixte de Recherche 944/7212, Paris Cancer Research Institute, Paris, France.
¹⁰ Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Saint-Antoine, AP-HP, Paris, France.
¹¹ Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France.
¹² Université de Paris, Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France. lionel.ades@aphp.fr.
¹³ Université de Paris, Institut de Recherche Saint-Louis, INSERM U944, Paris, France. lionel.ades@aphp.fr.

^# Contributed equally.

No abstract available

References

1. Adès L, Itzykson R, Fenaux P. Myelodysplastic syndromes. Lancet. 2014;383:2239–52. - DOI
1. Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300. - DOI
1. Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol. 2013;26:327–36. - DOI
1. Oh Y-J, Shin D-Y, Hwang SM, Kim S-M, Im K, Park HS, et al. Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome. Korean J Intern Med. 2020;35:457–64. - DOI
1. Fraison J-B, Mekinian A, Grignano E, Kahn J-E, Arlet J-B, Decaux O, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–7. - DOI